SELLAS Life Sciences Group, Inc. (SLS) Tops Q1 EPS by 2c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q1 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results